Cas:6098-86-8 p-dimethylaminophenylfluorone manufacturer & supplier

Chemical Name:p-dimethylaminophenylfluorone

CAS.NO:6098-86-8

Synonyms:p-dimethylaminophenylfluorone

Molecular Formula:C₂₁H₁₇NO₅

Molecular Weight:363.36300

HS Code:2932999099

Physical and Chemical Properties:

Melting point:N/A

Boiling point:436.6ºC at 760 mmHg

Density:1.324g/cm3

Index of Refraction:1.606

PSA:94.14000

Exact Mass:363.11100

LogP:3.74760

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like p-dimethylaminophenylfluorone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-dimethylaminophenylfluorone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,p-dimethylaminophenylfluorone Use and application,p-dimethylaminophenylfluorone technical grade,usp/ep/jp grade.

Related News: Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections. p-dimethylaminophenylfluorone manufacturer Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. p-dimethylaminophenylfluorone supplier Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business. p-dimethylaminophenylfluorone vendor In order to seize the highest point of profits, international industry giants have adjusted their development strategies, concentrated their energies on the two ends of the smile curve-research and development and end products, and shifted production links such as intermediates and APIs outward. A division of labor model has been formed. p-dimethylaminophenylfluorone factory INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.